Table of Content




1. Executive Summary


2. Global Cancer Biomarkers Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cancer Biomarkers Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Cancer Biomarkers Market by Type
3.3.1: Protein
3.3.2: Genetic
3.3.3: Others

3.4: Global Cancer Biomarkers Market by Cancer Type
3.4.1: Lung
3.4.2: Breast
3.4.3: Leukemia
3.4.4: Melanoma
3.4.5: Colorectal
3.4.6: Prostate
3.4.7: Thyroid
3.4.8: Kidney
3.4.9: Others

3.5: Global Cancer Biomarkers Market by Profiling Technology
3.5.1: Omics
3.5.2: Imaging
3.5.3: Immunoassay
3.5.4: Bioinformatics
3.5.5: Others

3.6: Global Cancer Biomarkers Market by Application
3.6.1: Diagnostics
3.6.2: R&D
3.6.3: Prognostics
3.6.4: Risk Management
3.6.5: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Cancer Biomarkers Market by Region
4.2: North American Cancer Biomarkers Market
4.2.2: North American Cancer Biomarkers Market by Application: Diagnostics, R&D, Prognostics, Risk Management, and Others


4.3: European Cancer Biomarkers Market
4.3.1: European Cancer Biomarkers Market by Cancer Type: Lung, Breast, Leukemia, Melanoma, Colorectal, Prostate, Thyroid, Kidney, and Others
4.3.2: European Cancer Biomarkers Market by Application: Diagnostics, R&D, Prognostics, Risk Management, and Others


4.4: APAC Cancer Biomarkers Market
4.4.1: APAC Cancer Biomarkers Market by Cancer Type: Lung, Breast, Leukemia, Melanoma, Colorectal, Prostate, Thyroid, Kidney, and Others
4.4.2: APAC Cancer Biomarkers Market by Application: Diagnostics, R&D, Prognostics, Risk Management, and Others


4.5: ROW Cancer Biomarkers Market
4.5.1: ROW Cancer Biomarkers Market by Cancer Type: Lung, Breast, Leukemia, Melanoma, Colorectal, Prostate, Thyroid, Kidney, and Others
4.5.2: ROW Cancer Biomarkers Market by Application: Diagnostics, R&D, Prognostics, Risk Management, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cancer Biomarkers Market by Type
6.1.2: Growth Opportunities for the Global Cancer Biomarkers Market by Cancer Type
6.1.3: Growth Opportunities for the Global Cancer Biomarkers Market by Profiling Technology
6.1.4: Growth Opportunities for the Global Cancer Biomarkers Market by Application
6.1.5: Growth Opportunities for the Global Cancer Biomarkers Market by Region

6.2: Emerging Trends in the Global Cancer Biomarkers Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cancer Biomarkers Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cancer Biomarkers Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: F. Hoffmann-La Roche
7.2: Thermo Fisher Scientific
7.3: Illumina
7.4: QIAGEN N.V.
7.5: Bio-Rad Laboratories